論文 - 詳細
| RRC ID | 72352 |
|---|---|
| 著者 | Noguchi T, Ikeda K, Yamamoto K, Yoshida I, Ashiba A, Tsuchiyama J, Shinagawa K, Yoshino T, Takata M, Harada M. |
| タイトル | Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells. |
| ジャーナル | Br J Haematol |
| Abstract |
Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl-2 expression. Suppression of LMP-1 expression by antisense oligodeoxynucleotides (AS-oligo) to LMP-1 inhibits proliferation, promotes apoptosis and suppresses Bcl-2 expression in EBV-transformed B cells. However, the function of LMP-1 expression in EBV-positive natural killer (NK) cell lymphoma cells has not been reported previously. We examined the function of LMP-1 in two EBV-positive NK cell lymphoma cell lines (NK-YS and YT) through suppressing LMP-1 expression by AS-oligo to LMP-1. The AS-oligo to LMP-1 suppressed LMP-1 mRNA and protein expression in two EBV-positive NK cell lymphoma cell lines, as well as in an EBV-transformed B-cell line (CMG-1). Proliferation was inhibited, apoptosis was induced and Bcl-2 expression was suppressed in CMG-1 cells, but none of these events were observed in NK-YS or YT cells. These results suggest that proliferation, inhibition of apoptosis and Bcl-2 expression in EBV-positive NK cell lymphoma cells are not directly regulated by LMP-1 as in EBV-transformed B-cell lines, but are probably mediated through other signal transducing systems. |
| 巻・号 | 114(1) |
| ページ | 84-92 |
| 公開日 | 2001-7-1 |
| DOI | 10.1046/j.1365-2141.2001.02887.x |
| PII | bjh2887 |
| PMID | 11472349 |
| MeSH | Adaptor Proteins, Signal Transducing Apoptosis / drug effects Blotting, Western Carrier Proteins / genetics* Cell Division / drug effects Cell Line, Transformed Cytoskeletal Proteins Gene Deletion Gene Expression / drug effects Herpesvirus 4, Human* Humans Intracellular Signaling Peptides and Proteins Killer Cells, Natural / metabolism Killer Cells, Natural / virology* LIM Domain Proteins Lymphoma, T-Cell / metabolism Lymphoma, T-Cell / virology* Oligonucleotides, Antisense / pharmacology* Proto-Oncogene Proteins c-bcl-2 / genetics Reverse Transcriptase Polymerase Chain Reaction Tumor Cells, Cultured |
| IF | 5.518 |
| オルトメトリクス指標 |
オルトメトリクス指標項目
|
| 最多言及媒体 | Patent(IFI CLAIMS) |
| 各媒体での言及数の合計 | 1 |
| 過去6か月間でのオルトメトリクス指標の変動値 | 0.0 |
| リソース情報 | |
| ヒト・動物細胞 | CGM1(RCB0566) |